Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,489.00
Bid: 2,488.00
Ask: 2,489.00
Change: 29.00 (1.18%)
Spread: 1.00 (0.04%)
Open: 2,465.00
High: 2,492.00
Low: 2,460.00
Prev. Close: 2,460.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Accounting Consequences of Quebec Judgment

5 Mar 2019 07:00

RNS Number : 8113R
British American Tobacco PLC
05 March 2019
 

5 March 2019

 

British American Tobacco p.l.c.

 

Accounting Consequences of Quebec Judgment

 

On 1 March 2019, the judgment in the two Quebec Class Action lawsuits against our subsidiary, Imperial Tobacco Canada Ltd. (ITCAN), and two other Canadian tobacco companies was publicly issued by the Quebec Court of Appeal in Montreal. The Court of Appeal has upheld the trial court's decision of May 2015, including the previously stated requirements for the defendants to deposit approximately CAD1.1 billion into a court escrow account.

 

As part of the 2015 decision, ITCAN was required to place CAD758 million (approximately £436 million) in escrow - the final payment of which was made in 2017. This deposit was held as an asset on the Group's balance sheet at the year-end (31 December 2018). 

 

Following the 1 March 2019 judgment, the Board of Directors of ITCAN have reassessed the recoverability of the deposit and have determined that the asset's recoverability is, under IFRS, less than virtually certain. Consequently, a provision of approximately £436 million will be charged to the Group's consolidated income statement in 2019. This will be treated as an adjusting expense. 

 

There will be no impact from this charge to the ratio of adjusted net debt to adjusted EBITDA, with this decision having no impact to cash flow in 2019.

 

The Board of Directors of ITCAN and the Group are monitoring developments. As previously stated, ITCAN intends to seek leave to appeal this judgment to the Supreme Court of Canada. 

 

British American Tobacco p.l.c. was not a party to the proceeding and is not a party to the judgment.

 

 

Enquiries:

 

Press Office

+44 (0)20 7845 2888 (24 hours) | @BATPress 

 

Investor Relations

Mike Nightingale / Rachael Brierley / John Harney

+44 (0)20 7845 1180 / 1519 / 1263

 

 

Forward looking statements

 

This announcement contains certain forward-looking statements, including "forward-looking" statements made within the meaning of Section 21E of the United States Securities Exchange Act of 1934. These statements are often, but not always, made through the use of words or phrases such as "believe," "anticipate," "could," "may," "would," "should," "intend," "plan," "potential," "predict," "will," "expect," "estimate," "project," "positioned," "strategy," "outlook", "target" and similar expressions. These include statements regarding our intentions, beliefs or current expectations concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the economic and business circumstances occurring from time to time in the countries and markets in which the Group operates.

 

All such forward-looking statements involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual future financial condition, performance and results to differ materially from the plans, goals, expectations and results expressed in the forward-looking statements and other financial and/or statistical data within this announcement. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are uncertainties related to the following: the impact of competition from illicit trade; the impact of adverse domestic or international legislation and regulation; changes in domestic or international tax laws and rates; adverse litigation and dispute outcomes and the effect of such outcomes on the Group's financial condition; changes or differences in domestic or international economic or political conditions; adverse decisions by domestic or international regulatory bodies; the impact of market size reduction and consumer down-trading; translational and transactional foreign exchange rate exposure; the impact of serious injury, illness or death in the workplace; the ability to maintain credit ratings and to fund the business under the current capital structure; the inability to develop, commercialise and roll-out Potentially Reduced-Risk Products; and changes in the market position, businesses, financial condition, results of operations or prospects of the Group.

 

It is believed that the expectations reflected in this announcement are reasonable but they may be affected by a wide range of variables that could cause actual results to differ materially from those currently anticipated. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. The forward-looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

No statement in this communication is intended to be a profit forecast and no statement in this communication should be interpreted to mean that earnings per share of BAT for the current or future financial years would necessarily match or exceed the historical published earnings per share of BAT.

 

Additional information concerning these and other factors can be found in the Company's filings with the U.S. Securities and Exchange Commission ("SEC"), including the Annual Report on Form 20-F filed on 15 March 2018 and Current Reports on Form 6-K, which may be obtained free of charge at the SEC's website, http://www.sec.gov, and the Company's Annual Reports, which may be obtained free of charge from the British American Tobacco website www.bat.com.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUSVRRKSAORUR
Date   Source Headline
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20223:30 pmRNSDirector Declaration
16th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20227:00 amRNSCorrection: Transaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 202211:50 amRNSPublication of Supplementary Prospectus
11th Feb 20224:30 pmRNSDirector/PDMR Shareholding
11th Feb 20221:30 pmRNSDirector/PDMR Shareholding
11th Feb 20221:30 pmRNSDirector/PDMR Shareholding
11th Feb 20221:30 pmRNSDirector/PDMR Shareholding
11th Feb 20221:30 pmRNSDirector/PDMR Shareholding
11th Feb 20227:01 amRNSBoard Changes
11th Feb 20227:01 amRNSShare Buyback Programme
11th Feb 20227:00 amRNSFinal Results
3rd Feb 20224:15 pmRNSCorrection: Director/PDMR Shareholding
3rd Feb 20222:00 pmRNSDirector/PDMR Shareholding
1st Feb 202212:00 pmRNSTotal Voting Rights
27th Jan 202212:00 pmRNSHolding(s) in Company
26th Jan 20222:30 pmRNSDirector Declaration
26th Jan 20222:00 pmRNSHolding(s) in Company
6th Jan 20221:00 pmRNSDirector/PDMR Shareholding
4th Jan 20225:00 pmRNSBlock listing Interim Review
4th Jan 20223:00 pmRNSTotal Voting Rights
21st Dec 202112:00 pmRNSDirector/PDMR Shareholding
14th Dec 20211:00 pmRNSDirector/PDMR Shareholding
13th Dec 20217:00 amRNSBranch Register: Dividend Finalisation Information
7th Dec 20217:00 amRNS2021 Second Half Pre-Close Trading Update
2nd Dec 20213:50 pmRNSDirector/PDMR Shareholding
1st Dec 20211:00 pmRNSTotal Voting Rights
19th Nov 202112:00 pmRNSDirector/PDMR Shareholding
15th Nov 20213:45 pmRNSTR-1: Notification of major holdings
15th Nov 20213:45 pmRNSDirector/PDMR Shareholding
15th Nov 20213:45 pmRNSDirector/PDMR Shareholding
15th Nov 20213:45 pmRNSDirector/PDMR Shareholding
15th Nov 20213:45 pmRNSDirector/PDMR Shareholding
15th Nov 20213:45 pmRNSDirector/PDMR Shareholding
4th Nov 20212:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20213:50 pmRNSDirector Declaration
1st Nov 20213:00 pmRNSTotal Voting Rights
26th Oct 20212:00 pmRNSDirector/PDMR Shareholding
21st Oct 20215:23 pmRNSPost Stabilisation Notice-British American Tobacco
18th Oct 20212:00 pmRNSTR-1: Notification of major holdings
8th Oct 20214:00 pmRNSDirector/PDMR Shareholding
8th Oct 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.